“Is looking” - so in other words, they aren’t doing this currently.
Elite has pivoted to primarily a GENERIC manufacturing company and has no marketed products being sold that would be based on patents Elite holds. If anything, this could potentially even help Elite if it happens.
“The administration unveiled a framework outlining the factors federal agencies should consider in deciding whether to use a controversial policy, known as march-in rights, **to take patents for drugs developed with taxpayer funds and share them with other pharmaceutical companies** if the public cannot ‘reasonably’ access the medications.”
Oh, share them with other companies? Like, generic manufacturers? Like possibly Elite? LOL.
As usual, you and the gang of dipshits have no clue what you’re talking about. Lmao.
Next.
News 
Market Data 
Discover 
